New Products: Foundation Medicine's FoundationOne Tests

Foundation Medicine has received approval from New York State Department of Health for its FoundationOne and Foundation One Heme tests, which use next-generation sequencing to analyze cancer mutations in solid and hematological tumors, respectively. The tests had previously been offered under conditional approval to physicians.